A research team in Trinity has uncovered a critical role for a protein called ‘PKM2’ in the regulation of immune cell types at the heart of multiple inflammatory diseases. The work identifies PKM2 as a potential therapeutic target for treating a host of diseases mediated by over-active immune cells, such as psoriasis and multiple sclerosis. Credit: Trinity...